Privia Health Group, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing condensed consolidated financial statements and related management discussion.
Key Highlights
- Total assets: Privia Health Group reported total assets of $1,488,581 thousand as of June 30, 2026, up from $1,369,378 thousand at December 31, 2025.
- Cash and cash equivalents: Cash declined to $412,200 thousand at June 30, 2026, from $479,685 thousand at December 31, 2025.
- Accounts receivable: Accounts receivable increased to $574,160 thousand from $400,902 thousand at year-end 2025.
- Accumulated deficit: The accumulated deficit narrowed to $144,198 thousand at June 30, 2026, from $156,310 thousand at December 31, 2025.
- Shares outstanding: As of July 31, 2026, the company had 127,734,207 shares of common stock outstanding.
- Total stockholders' equity: Total stockholders' equity grew to $838,073 thousand from $790,943 thousand at December 31, 2025.
Privia Health Group Balance Sheet Movements in the First Half of 2026
According to the filing, Privia Health Group, Inc. (Nasdaq Global Select Market: PRVA) reported total assets of $1,488,581 thousand as of June 30, 2026, compared to $1,369,378 thousand as of December 31, 2025. The company disclosed that current assets rose to $1,025,266 thousand from $911,001 thousand, driven primarily by an increase in accounts receivable from $400,902 thousand to $574,160 thousand, partially offset by a decrease in cash and cash equivalents from $479,685 thousand to $412,200 thousand.
On the liabilities side, the filing reported that total liabilities increased to $650,508 thousand from $578,435 thousand at year-end 2025. Provider liability, listed as a current liability, rose to $541,368 thousand from $469,516 thousand over the same period. Accounts payable and accrued expenses declined modestly to $91,010 thousand from $96,804 thousand, according to the filing.
The filing reported that total stockholders' equity attributable to Privia Health Group, Inc. was $782,329 thousand at June 30, 2026, compared to $737,217 thousand at December 31, 2025. The accumulated deficit decreased to $144,198 thousand from $156,310 thousand, while additional paid-in capital increased to $925,264 thousand from $892,291 thousand. Common stock was reported at $0.01 par value, with 126,289,983 shares issued and outstanding as of June 30, 2026. Non-controlling interest stood at $55,744 thousand, up from $53,726 thousand. The filing contains forward-looking statements that, as the company noted, are subject to risks and uncertainties described in its cautionary language and Annual Report on Form 10-K for the year ended December 31, 2025.
What Was Disclosed
Privia Health Group filed its Form 10-Q for the quarter ended June 30, 2026, presenting condensed consolidated balance sheet data showing growth in total assets, accounts receivable, and stockholders' equity, alongside a reduction in cash and a narrowing accumulated deficit.




Please wait processing your request...